
Custom crystal commemorating the submission of a New Drug Application (NDA) to the FDA. The application for Impel NeuroPharma’s migraine treatment INP104 was supported by a Phase 3, open-label safety and tolerability trial. (20ALJ356)

Custom crystal commemorating the submission of a New Drug Application (NDA) to the FDA. The application for Impel NeuroPharma’s migraine treatment INP104 was supported by a Phase 3, open-label safety and tolerability trial. (20ALJ356)
"*" indicates required fields
Lucite Embedments: What Works and What Doesn't? Lucite embedments can have extraordinary appeal and perceived value among recipients. The piece shown above is a great example. It's not hard to imagine how a commemorative recognizing the...
"Custom crystal awards" is a phrase that gets searched pretty frequently online. And you'll get plenty of results if you try it yourself. But many of the results you'll get are missing some crucial information. In some cases, they're just...
George Shultz and Mikhail Gorbachev might at first seem unlikely candidates to have inspired a youth award. Shultz, the former U.S. Secretary of State under Ronald Reagan, celebrated his 100th birthday in December. Gorbachev, the former...